NextPlat Corp (NXPL): Entry into a Material Definitive Agreement
NextPlat Corp (NXPL) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex_988389.htm EXHIBIT 10.1 MEMBERSHIP INTEREST PURCHASE AGREEMENT ex_988389.htm Exhibit 10.1 MEMBERSHIP INTEREST PURCHASE AGREEMENT by and among RON G. SCOTT, an individual and PROGRESSIVE CARE, LLC, a Nevada Limited Liability Company dated as of July 14 , 2026 Exhibits
How this was made
The 30-second read
Why it matters
This is an acquisition-related definitive agreement disclosure, which can change growth expectations and risk profile (integration, regulatory, and operating liabilities). However, the excerpt does not include the purchase consideration or deal timeline, limiting immediate valuation impact.
Market read
Traders may reassess NXPL’s acquisition pipeline and near-term execution risk, but the excerpt lacks deal economics needed for a strong directional trade.
What to watch
Key trader-relevant items likely reside later in the exhibit (consideration, earnouts, reps and warranties, regulatory approvals, noncompete scope, and closing conditions), which are not shown in the provided text.
Background
The 8-K (Item 1.01) attaches a Membership Interest Purchase Agreement for the acquisition of 100% of SCOTT’S PHARMACY, LLC, a Florida pharmacy operating in Molino.
Ticker impact
NextPlat Corp filed an 8-K stating it entered a material definitive agreement, with an exhibit detailing a membership interest purchase for a pharmacy business.
Near-term volatility possible on acquisition expectations, but direction is unclear without consideration and funding details.
This is a primary SEC disclosure (Item 1.01) tied to a definitive agreement, yet the provided text is largely boilerplate definitions and does not include key economic terms.
Market effects
Could indicate continued consolidation in community pharmacy ownership, but no sector-wide read-across is provided.
Deal is described as operating in Molino, Florida, implying localized competitive and reimbursement dynamics, not broader regional effects.
No global macro or cross-border implications mentioned.
Counterpoint
Without disclosed purchase price, financing, or closing conditions in the excerpt, the market may discount the news as low-information until later amendments or closing disclosures.
Key entities
- issuerNextPlat Corp
Subject of the 8-K filing and the company entering a material definitive agreement.
- targetSCOTT’S PHARMACY, LLC
Florida limited liability company whose 100% membership interests are being purchased under the agreement.
- purchaserPROGRESSIVE CARE, LLC
Named purchaser in the membership interest purchase agreement exhibit.
- sellerRON G. SCOTT
Named seller owning 100% of the target’s membership interests.
